m-Methoxy-a-methylphenethylamine en es it fr

Categoria

m-Methoxy-a-methylphenethylamine Nombres de marca, m-Methoxy-a-methylphenethylamine Analogos

m-Methoxy-a-methylphenethylamine Marca los nombres de mezcla

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • m-Methoxy-a-methylphenethylamine Formula quimica

    C9H13N

    m-Methoxy-a-methylphenethylamine RX enlace

    http://www.rxlist.com/cgi/generic3/adderallxr.htm

    m-Methoxy-a-methylphenethylamine FDA hoja

    m-Methoxy-a-methylphenethylamine MSDS (hoja de seguridad de materiales)

    m-Methoxy-a-methylphenethylamine Sintesis de referencia

    Patente de EE.UU.. 1879003, (1932)

    m-Methoxy-a-methylphenethylamine Peso molecular

    135.206 g/mol

    m-Methoxy-a-methylphenethylamine Punto de fusion

    Volatizes slowly at room temperature

    m-Methoxy-a-methylphenethylamine H2O Solubilidad

    Ligeramente

    m-Methoxy-a-methylphenethylamine Estado

    Solid

    m-Methoxy-a-methylphenethylamine LogP

    1.799

    m-Methoxy-a-methylphenethylamine Formas de dosificacion

    Cápsulas

    m-Methoxy-a-methylphenethylamine Indicacion

    Para el tratamiento del Trastorno de Déficit de Atención con Hiperactividad (TDAH) y la narcolepsia en niños.

    m-Methoxy-a-methylphenethylamine Farmacologia

    La anfetamina y la dextroanfetamina, no catechloamine agentes sypathomimetic, se utilizan en combinación para tratar el déficit de atención con hiperactividad (TDAH) o la narcolepsia. Adderall se compone de equivalente cantidades de anfetaminas aspartato, el sulfato de anfetamina, la dextroanfetamina sacarato, y sulfato de dextroanfetamina.

    m-Methoxy-a-methylphenethylamine Absorcion

    Forma moléculas absorben fácilmente que son altamente solubles en lípidos

    m-Methoxy-a-methylphenethylamine Toxicidad

    LD50 = 180 mg / kg (sc, en la rata). Los síntomas de presentación más comunes observados son agitación, alucinaciones, comportamiento suicida, y dolor en el pecho.

    m-Methoxy-a-methylphenethylamine Informacion de Pacientes

    Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

    m-Methoxy-a-methylphenethylamine Organismos afectados

    Humanos y otros mamíferos